United States · FDA National Drug Code directory

HYQVIA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0944-2513_23f408f3-d160-4864-afe2-8d112a951887
Product NDC: 0944-2513
Form: KIT
Composition / generic term: Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase
Labeler: Takeda Pharmaceuticals America, Inc.
Marketing category: BLA
Marketing start / end (source format): 20140912
Source listing expiry: 20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

1 KIT in 1 CARTON (0944-2513-02) * 200 mL in 1 VIAL, GLASS (0944-2718-20) * 10 mL in 1 VIAL, GLASS (0944-2723-03) · 0944-2513-02

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →